Change the scenario for Patients at High Risk of Type 2 Diabetes

November 17, 2026
67
УДК:  УДК 616.379-008.64
Resume

Being at high risk for type 2 diabetes does not mean a diagnosis is inevitable. Timely detection of carbohydrate metabolism disorders, lifestyle modifications, and the appropriate prescription of metformin can reduce the likelihood of developing the disease or delay its onset. On the occasion of World Diabetes Day, Acino, part of Arcera, proposes a shift in approach: moving away from a focus on high diabetes risk in patients toward timely prevention and positive lifestyle changes.

References

  • 1. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP). https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes prevention-program-dpp
  • 2. American Diabetes Association Professional Practice Committee for Diabetes. Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S50–S60. https://doi.org/10.2337/dc26-S003
  • 3. Державний реєстр лікарських засобів України. Глюкофаж XR (Glucophage XR): реєстраційне посвідчення № UA/3994/02/01. 2025. https://drlz.moz.gov.ua/register/product/17834
  • 4. Knowler WC, Doherty L, Edelstein SL, et al. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol. 2025;13(6):469–481. https://doi.org/10.1016/S2213-8587(25)00022-1
  • 5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865.
  • 6. Adler AI, Coleman RL, Leal J, et al. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). Lancet. 2024;404(10448):145–155. https://doi.org/10.1016/S0140-6736(24)00537-3
  • 7. IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes — 2025. https://idf.org/t2d-cpr-2025 https://international-diabetes-federation.s3.eu-west 1.amazonaws.com/media/uploads/2025/05/IDF_Rec_2025.pdf